Canadian Hematology Society

What Canadian Hematology Society does

The Canadian Hematology Society (CHS) is a non-profit professional medical society founded in 1971 and headquartered at 4 Cataraqui Street, Suite 310, Kingston, Ontario, Canada. It serves Canadian physicians, scientists, and allied health professionals with an interest in hematology, operating as the recognized collective voice of the specialty. CHS delivers a portfolio of membership services including accredited continuing education (RCPSC Section 1 webinars, Section 3 self-assessment case studies, and the six-part QIPS webinar series), research recognition programs (Annual Research Abstract Awards, John H. Crookston Award, Stephen Couban Award, Paper of the Year, RK Smiley Research Grant, Lifetime Achievement, Early Career, and Innovation/Quality/Education Awards), the Pan-Canadian Case Study Challenge, and official endorsements of clinical practice guidelines (e.g., Choosing Wisely Canada recommendations, 2025 AABB/ICTMG platelet transfusion guidelines).

The society runs on a community-led go-to-market with a WordPress-hosted digital presence (canadianhematologysociety.org), a members-only portal, a monthly e-newsletter, and a Twitter presence (@CHSChief). Distribution is exclusively direct-to-member through the online portal and a self-serve website, with no field sales motion. Revenue is generated through annual membership dues (a freemium associate tier is offered to eligible professionals, with standard paid membership providing full access) and sponsorship arrangements with industry partners supporting educational programs, events, and research. No parent company, venture capital, or private equity ownership is identified; the society is independently member-supported and governed by a Board of Directors.

Operationally, CHS engages in active ecosystem partnerships across Canadian and international hematology — including Choosing Wisely Canada, the European Hematology Association, CANO/ACIO, HAEi, the International Society for Laboratory Hematology, and several specialty conferences — and participates in co-hosted international events in 2026. No AI/ML capabilities, proprietary technology stack, mobile applications, or APIs are disclosed; the technology layer is limited to standard web content delivery and secure member authentication.

Name

Canadian Hematology Society

Legal name

Canadian Hematology Society

Website

https://canadianhematologysociety.org

Company type

Private

Founded year

1971

Operating status

Operating

Headcount range

1–10 employees

Short description

The Canadian Hematology Society is a 1971-founded non-profit professional medical society headquartered in Kingston, Ontario, serving Canadian physicians, scientists, and allied health professionals in hematology through membership, accredited continuing education, research grants and awards, and clinical guideline endorsements.

Ownership category

akta.pro rank

Product category

Professional Medical Society

NAICS

Professional Organizations (81392), Professional Organizations (813920), Business Associations (813910)

SIC

Services-Membership Organizations (8600), Services-Educational Services (8200)

akta.pro primary industry

Medical Hematology (Benign Hematology) (HLAKAFAA)

akta.pro secondary industries

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC), Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ), Continuing Education (CE/CPD) & Provider Accreditation Bodies (EDADACAF)

Keywords

• Hematology professional society
• Medical continuing education
• Clinical practice guidelines
• Hematology research grants
• Professional membership organization

Headquarters

HQ city

Ottawa

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Membership Dues: The society generates revenue through membership fees from physicians, scientists, and allied health professionals in Canada who join the Canadian Hematology Society.
2. Sponsorship: The society offers sponsorship opportunities for industry partners to support educational programs, events, and research initiatives.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

The Canadian Hematology Society is a national professional membership organization that delivers continuing medical education (accredited webinars and case studies), research grants and abstract awards, clinical practice guideline endorsements, and advocacy for physicians, scientists, and allied health professionals working in hematology across Canada. Its core deliverables are membership services, accredited learning modules, research funding programs, and recognized awards in the hematology field.

Product overview

The Canadian Hematology Society operates as a professional membership organization rather than a commercial product company. Its offerings consist of membership services, continuing medical education programs (accredited webinars and case studies with CME credits), research awards and grants (including the RK Smiley Research Grant, John H. Crookston Award, and Stephen Couban Award), quality improvement initiatives (QIPS webinar series in partnership with Choosing Wisely Canada), and clinical guideline endorsements. The society provides a member portal with flexible online learning, self-assessment credits, and printable certificates. Its core value proposition is professional education, research support, and clinical guidance for hematology practitioners across Canada.

Differentiator

Problem solved

Functional benefit

Products and services

• CHS Membership Professional membership program for physicians, scientists, and allied health professionals interested in hematology in Canada. Provides access to the member portal, continuing education resources (accredited webinars and case studies), research awards, clinical guidelines, and networking opportunities. Annual subscription; complimentary associate membership available for eligible professionals.
• CHS Accredited Webinars Free accredited group learning activities (Section 1) for CHS members, developed by and for professionals in the hematology field. Provides CME credits through the Royal College of Physicians and Surgeons of Canada (RCPSC) and approved by CAP.
• CHS Accredited Case Studies
• Annual Research Abstract Awards Research awards program for hematology trainees in Canada, including the John H. Crookston Award (best paper by a resident) and Stephen Couban Award (best abstract by a Canadian resident in leukemia or stem-cell transplantation), recognizing excellence in hematology research presentations.
• RK Smiley Research Grant Program
• Pan-Canadian Case Study Challenge
• Quality Improvement and Patient Safety (QIPS) Webinar Series

Quantifiable outcome

• 61 new Choosing Wisely Canada recommendations developed
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core and minor.

• Choosing Wisely CanadacoreStrategic or Co-development PartnerThe Canadian Hematology Society is an active partner with Choosing Wisely Canada, a clinician-led campaign launched in 2014 to reduce unnecessary tests and treatments. CHS participates in the CHS-CWC Working Group, develops quality improvement recommendations, and supports the Hospital Designation Program. The society offers a 6-part QIPS webinar series aligned with Choosing Wisely principles.
• HAEi (Hereditary Angioedema International)minorStrategic or Co-development PartnerCo-hosting the 2026 HAEi Regional Conference Americas in Ottawa, Canada from October 23-25, 2026. The conference focuses on hereditary angioedema with tracks for patients, caregivers, youngsters, and scientific professionals.
• CANO/ACIO (Canadian Association of Oncology Nurses)coreStrategic or Co-development PartnerCo-hosting the 2026 CANO/ACIO Annual Conference (38th Annual) in Montreal, Quebec from October 22-25, 2026. The conference brings together oncology nurses across Canada to advance excellence in oncology nursing care.
• EHA (European Hematology Association)coreStrategic or Co-development PartnerCo-hosting the CHT@EHA pre-conference program at EHA 2026 in Stockholm, Sweden on June 10, 2026. The program offers rapid-fire presentations highlighting key sessions from the EHA meeting, followed by a networking reception.
• Toronto Complement ConferenceminorStrategic or Co-development PartnerPromoting the 2026 Toronto Complement Conference scheduled for September 25-26, 2026. Topics include modern PNH management, transplant-associated TMA, catastrophic antiphospholipid syndrome, and sickle disease.
• ISHL (International Society for Laboratory Hematology)minorStrategic or Co-development PartnerPromoting the ISLH Annual Congress at Edinburgh International Convention Centre, April 17-19, 2026. The 39th International Symposium on Technical Innovations in Laboratory Hematology.
• 14th International Symposium on Hodgkin LymphomaminorStrategic or Co-development PartnerPromoting ISHL14 scheduled for October 3-5, 2026 in Cologne, Germany. The international symposium brings together experts in Hodgkin lymphoma research and treatment.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• International Society of Hematology: A global general hematology society spanning multiple regions. ISH is comparable to CHS in mission as a general hematology umbrella organization, though at significantly broader geographic scope.
• European Hematology Association: The leading pan-European hematology society covering 27+ countries. EHA is a direct peer to CHS in mission and offerings (education, congresses, research grants) and is also an active CHS partner — making it a benchmark peer for CHS's continental programming ambition.
• International Society on Thrombosis and Haemostasis: A global scientific society focused on thrombosis, hemostasis, and vascular biology. ISTH overlaps with CHS's clinical guideline endorsement work (e.g., the AABB/ICTMG Platelet Transfusion Guidelines) and serves a partially overlapping physician-researcher audience.

Direct peers

• British Society for Haematology: The national hematology society of the United Kingdom. BSH closely mirrors CHS's structure and product set — membership, accredited continuing education, clinical guidelines, and research awards — making it one of the most directly comparable peers.
• American Society of Hematology: The premier hematology professional society in the United States. ASH is a direct peer to CHS as both are membership-based professional societies serving physicians, scientists, and allied health professionals in hematology, with overlapping offerings in continuing education, research awards, clinical guidelines, and advocacy.
• Hematology Society of Australia and New Zealand: The peak hematology body for Australia and New Zealand. HSANZ serves a similar English-speaking Commonwealth medical community with comparable offerings in CME, scientific meetings, and clinical guidelines, making it a strong structural peer.

Regional players

• Canadian Medical Association: Canada's national medical association representing physicians broadly. CMA is an adjacent peer — overlapping with CHS in Canadian physician membership, advocacy, and CME, but operating at a multi-specialty level rather than focusing on hematology.

Emerging players

• International Society for Laboratory Hematology: An international society focused on technical innovations in laboratory hematology. ISLH is a direct partner with CHS (promoting the 2026 ISLH Annual Congress in Edinburgh) and an emerging peer in the laboratory-hematology subset of CHS's mandate.
• Society of Hematologic Oncology: A focused society for hematologic oncology professionals. SOHO overlaps with CHS's malignant hematology constituency and competes for the same hematologist-oncologist audience with a more subspecialized annual meeting.

Others

• Choosing Wisely Canada: A national clinician-led campaign to reduce unnecessary tests and treatments. Choosing Wisely Canada is an OTHERS peer — not a competitor, but a core CHS strategic partner through the CHS-CWC Working Group and aligned QIPS programming.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/chschief
• LinkedInlinkedin.com/company/canadian-hematology-society

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canadian Hematology Society